EXPERT REACTION: Exploring genetic diagnostic options for autism in Aotearoa

Publicly released:
New Zealand
Photo by Warren Umoh on Unsplash
Photo by Warren Umoh on Unsplash

A genetic screening study of over 200 autistic New Zealanders found almost 30% had genes that are 'causal', or 'likely causal', of autism. The results were based on DNA samples from the participants as well as 101 non-autistic family members, and used screening procedures currently not widely available in Aotearoa. The rate of genetic diagnosis was similar to those reported by other larger studies overseas. The authors say that having a conclusive genetic diagnosis can help with personalised healthcare, access to support services, and screening for co-occurring health conditions.

Expert Reaction

These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.

Dr Hiran Thabrew, Child psychiatrist and Paediatrician, Te Ara Hāro - Centre for Infant, Child and Adolescent mental health, University of Auckland

Why, if you are Autistic, does it matter what genes you possess? The reason that over 200 children and adults from across Aotearoa volunteered to participate in this study of known causal and likely causal genes for Autism is that understanding why they are neurodiverse can be helpful.

"It can help to know why one experiences the world in a different way to others, to which physical and mental health issues one might be more prone and to counter multiple issues that lead to increased health service use and double the rate of death by early adulthood.

"Arguing for a broadening of genetic testing for Autistic individuals using flexible and customised gene sequencing, the results of the study by Musgrave and colleagues also suggest that genetic testing is more likely to yield dividends among those experiencing comorbid health issues.

"We are nowhere near personalising care for Autistic individuals on the basis of genetic testing, especially in Aotearoa’s under-resourced publicly funded health services. However, understanding genetic profiles and their clinical associations are vital steps on the journey.

Last updated:  19 Sep 2024 9:46am
Contact information
Contact details are only visible to registered journalists.
Declared conflicts of interest None declared.

Dr Jessie Jacobsen, Senior Lecturer in the School of Biological Sciences, University of Auckland

One of the important aspects of this research is that our genetic approach is successful for autistic individuals regardless of neurological differences, including adults who grew up prior to autism being widely recognised. Our discoveries have had life-changing impacts for individuals and their whānau, including personalised clinical management for co-occurring conditions.

"Importantly, for some families, having a precise genetic answer marked the end of a long search for an accurate diagnosis. Our current and future work will improve long-term clinical, social, and educational opportunities for individuals and families, supporting their wide range of skills, interests, and personalities.

Last updated:  17 Sep 2024 10:34am
Contact information
Contact details are only visible to registered journalists.
Declared conflicts of interest Dr Jacobsen is an author of the paper.
Journal/
conference:
Journal of the Royal Society of New Zealand
Research:Paper
Organisation/s: University of Auckland, Auckland City Hospital
Funder: Open Access funding provided by the Qatar National Library. We thank Kristine Boxen, the Genomics Centre, Auckland Science Analytical Services, The University of Auckland, for assistance with Sanger sequencing, and computing resources were kindly provided by the New Zealand eScience Infrastructure (NeSI).
Media Contact/s
Contact details are only visible to registered journalists.